Exploration of cornea permeable calpain inhibitors as anticataract agents

被引:34
作者
Nakamura, M [1 ]
Yamaguchi, M [1 ]
Sakai, O [1 ]
Inoue, J [1 ]
机构
[1] Senju Pharmaceut Co Ltd, Res Lab, Nishi Ku, Kobe, Hyogo 6512241, Japan
关键词
D O I
10.1016/S0968-0896(02)00612-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To explore cornea permeable calpain inhibitors, four compounds displaying different characteristics were designed and synthesized based on the known potent calpain inhibitor, peptidyl aldehyde SJA6017. Two approaches were adopted; an improvement in the physicochemical properties, and conversion of the active aldehyde. The water-soluble peptidyl aldehyde 1 containing a pyridine ring at the P3 site showed a modest inhibition against calpains and an improvement of corneal permeability in comparison with SJA6017. Replacement of the aldehyde of SJA6017 by an alpha-ketoamide provided compound 2 that was approximately equipotent with SJA6017, but it was extremely water-in soluble. However, compound 3, in which the aldehyde was converted into a cyclic hemiacetal, proved to be a less potent calpain inhibitor than SJA6017, but demonstrated excellent transcorneal permeability. Further modification generating the cyclic hermacetal 4 containing a thiourea linker between the P3 and P2 sites exhibited potent inhibitory activities, high cornea permeability and excellent efficacy in the rat lens culture cataract model. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1371 / 1379
页数:9
相关论文
共 14 条
[1]   SUPERIOR PREVENTION OF CALCIUM IONOPHORE CATARACT BY E64D [J].
AZUMA, M ;
DAVID, LL ;
SHEARER, TR .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1180 (02) :215-220
[2]   POSTISCHEMIC ADMINISTRATION OF AK275, A CALPAIN INHIBITOR, PROVIDES SUBSTANTIAL PROTECTION AGAINST FOCAL ISCHEMIC BRAIN-DAMAGE [J].
BARTUS, RT ;
BAKER, KL ;
HEISER, AD ;
SAWYER, SD ;
DEAN, RL ;
ELLIOTT, PJ ;
STRAUB, JA .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1994, 14 (04) :537-544
[3]   A COOMASSIE BRILLIANT BLUE G-250-BASED COLORIMETRIC ASSAY FOR MEASURING ACTIVITY OF CALPAIN AND OTHER PROTEASES [J].
BUROKERKILGORE, M ;
WANG, KKW .
ANALYTICAL BIOCHEMISTRY, 1993, 208 (02) :387-392
[4]   A COMPARATIVE IN-VITRO STUDY OF TRANSDERMAL ABSORPTION OF ANTIEMETICS [J].
CALPENA, AC ;
BLANES, C ;
MORENO, J ;
OBACH, R ;
DOMENECH, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (01) :29-33
[5]   SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses [J].
Fukiage, C ;
Azuma, M ;
Nakamura, Y ;
Tamada, Y ;
Nakamura, M ;
Shearer, TR .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1997, 1361 (03) :304-312
[6]   The calpain family and human disease [J].
Huang, YH ;
Wang, KKW .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (08) :355-362
[7]  
ONO Y, 1999, CALPAIN PHARM TOXICO, P1
[8]   New synthetic technology for efficient construction of α-hydroxy-β-amino amides via the Passerini reaction [J].
Semple, JE ;
Owens, TD ;
Nguyen, K ;
Levy, OE .
ORGANIC LETTERS, 2000, 2 (18) :2769-2772
[9]   SELENITE CATARACT - A REVIEW [J].
SHEARER, TR ;
DAVID, LL ;
ANDERSON, RS .
CURRENT EYE RESEARCH, 1987, 6 (02) :289-300
[10]   Proteolysis by m-calpain enhances in vitro light scattering by crystallins from human and bovine lenses [J].
Shih, M ;
David, LL ;
Lampi, KJ ;
Ma, H ;
Fukiage, C ;
Azuma, M ;
Shearer, TR .
CURRENT EYE RESEARCH, 2001, 22 (06) :458-469